Market closed

CEL-SCI/$CVM

14:30
15:25
16:15
17:10
18:00
1D1W1MYTD1Y5YMAX

About CEL-SCI

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

Ticker

$CVM

Trading on

AMEX

Industry

Biotechnology

Employees

44

CEL-SCI Metrics

BasicAdvanced
$45M
Market cap
-
P/E ratio
-$0.58
EPS
0.66
Beta
-
Dividend rate
$45M
0.66
$3.23
$0.49
840K
0.643
0.079
117.595
143.185
-36.79%
-61.40%
-250.20%
4.47
4.56
-1.833
-25.35%
-13.12%

What the Analysts think about CEL-SCI

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for CEL-SCI stock.

CEL-SCI Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

CEL-SCI Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CVM

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for CEL-SCI stock?

CEL-SCI (CVM) has a market cap of $45M as of December 25, 2024.

What is the P/E ratio for CEL-SCI stock?

The price to earnings (P/E) ratio for CEL-SCI (CVM) stock is 0 as of December 25, 2024.

Does CEL-SCI stock pay dividends?

No, CEL-SCI (CVM) stock does not pay dividends to its shareholders as of December 25, 2024.

When is the next CEL-SCI dividend payment date?

CEL-SCI (CVM) stock does not pay dividends to its shareholders.

What is the beta indicator for CEL-SCI?

CEL-SCI (CVM) has a beta rating of 0.66. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.